Authors: SIBILLE M BRESSON V JANIN A BOUTOUYRIE B REY J DURAND DV

Citation: M. Sibille et al., CRITICAL LIMITS TO DEFINE A LAB ADVERSE EVENT DURING PHASE-I STUDIES - A STUDY IN 1134 SUBJECTS, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 81-86

Authors: SIBILLE M LASSONERY LG JANIN A DEIGAT N BOUTOUYRIE B DURAND DV

Citation: M. Sibille et al., UPPER LIMIT OF PLASMA ALANINE AMINO TRANSFERASE DURING PHASE-I STUDIES, European Journal of Clinical Pharmacology, 47(5), 1995, pp. 417-421